Prof. Dr. med. Sibylle Loibl spoke about the future of drug evaluation and the challenges of creating an innovation-friendly and patient-centered healthcare system.
This year, GBG is represented at the DKK with three scientific posters, presenting current results from its study activities.
At the 48th San Antonio Breast Cancer Symposium 2025 GBG is taking part in the following presentations.
GBG @ ESMO 2025 in Berlin!
Go ahead and get tested!
